STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Clinical trials for STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted pill after surgery may extend life for lung cancer patients
Disease control OngoingThis study tests whether taking erlotinib (a targeted therapy pill) after surgery helps people with a specific type of lung cancer (EGFR-mutant) live longer compared to just watching and waiting. About 390 patients with early-stage lung cancer that was fully removed took part. Th…
Matched conditions: STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Immunotherapy after surgery could keep lung cancer from coming back
Disease control OngoingThis study tested whether giving the immunotherapy drug nivolumab after lung cancer surgery and chemotherapy helps prevent the cancer from returning. It involved 903 people with stage IB-IIIA non-small cell lung cancer who had their tumors surgically removed. Half received nivolu…
Matched conditions: STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 14, 2026 13:09 UTC
-
Lung cancer study aims to match patients with precision treatments
Knowledge-focused OngoingThis study screens people with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. By analyzing the genes in their tumor tissue, doctors hope to identify which patients might benefit from specific targeted therapies. The goal is to better persona…
Matched conditions: STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 07:23 UTC